{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:25:12Z","timestamp":1792844712959,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.vaccine.2021.04.027","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T10:12:11Z","timestamp":1621851131000},"page":"3544-3559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Feasibility assessment of measles and rubella eradication"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6579-3513","authenticated-orcid":false,"given":"William J.","family":"Moss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Shendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Lindstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7258-6029","authenticated-orcid":false,"given":"Katrina","family":"Kretsinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.04.027_b0005","unstructured":"World Health Organization. Resolution WHA 70.14: Strengthening immunization to achieve the goals of the global vaccine action plan. Geneva, World Health Assembly 70, 2017 (http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA70\/A70_R14-en.pdf)."},{"key":"10.1016\/j.vaccine.2021.04.027_b0010","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/infdis\/jir100","article-title":"Proceedings of the Global Technical Consultation to assess the feasibility of measles eradication, 28\u201330 July 2010","volume":"204","author":"World Health Organization","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.027_b0015","unstructured":"World Health Organization. Meeting of the Strategic Advisory Group of Experts on Immunization, November 2010. Summary, conclusions and recommendations. Weekly Epidemiological Record 2011,86:1\u201316."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.04.027_b0020","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.vaccine.2017.09.026","article-title":"Measles and Rubella Global Strategic Plan 2012\u20132020 midterm review","volume":"36","author":"Orenstein","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.027_b0025","unstructured":"Recommendations of the International Task Force for Disease Eradication. Morbidity and Mortality Weekly Report 1993;42(RR-16):1-38. (available at https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00025967.htm)"},{"key":"10.1016\/j.vaccine.2021.04.027_b0030","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.15585\/mmwr.mm6747a6","article-title":"Progress toward regional measles elimination - worldwide, 2000\u20132017","volume":"67","author":"Dabbagh","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.04.027_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149160","article-title":"Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996\u20132010: a systematic review","volume":"11","author":"Vynnycky","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.04.027_b0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/21645515.2018.1532257","article-title":"The impact of measles-rubella vaccination on the morbidity and mortality from congenital rubella syndrome in 92 countries","volume":"15","author":"Vynnycky","year":"2019","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2021.04.027_b0045","unstructured":"https:\/\/sustainabledevelopment.un.org"},{"key":"10.1016\/j.vaccine.2021.04.027_b0050","unstructured":"https:\/\/www.ghsagenda.org"},{"key":"10.1016\/j.vaccine.2021.04.027_b0055","unstructured":"https:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/GVAP_doc_2011_2020\/en\/"},{"key":"10.1016\/j.vaccine.2021.04.027_b0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2471\/BLT.16.178475","article-title":"Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001\u20132020","volume":"95","author":"Ozawa","year":"2017","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2021.04.027_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2019.06.025","article-title":"Anthropometric, cognitive, and schooling benefits of measles vaccination: Longitudinal cohort analysis in Ethiopia, India, and Vietnam","author":"Nandi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.027_b0070","doi-asserted-by":"crossref","first-page":"937","DOI":"10.15585\/mmwr.mm6842a1","article-title":"Global routine vaccination coverage, 2018","volume":"68","author":"Peck","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.04.027_b0075","series-title":"Global eradication of measles: report by the Secretariat","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.vaccine.2021.04.027_b0080","unstructured":"Reported case data: measles cases (2018) from World Health Organization, as of July 15, 2019 (http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tsincidencemeasles.html."},{"key":"10.1016\/j.vaccine.2021.04.027_b0085","doi-asserted-by":"crossref","first-page":"587","DOI":"10.15585\/mmwr.mm6826a3","article-title":"Genetic characterization of measles and rubella viruses detected through global measles and rubella elimination surveillance, 2016\u20132018","volume":"68","author":"Brown","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.04.027_b0090","first-page":"544","article-title":"Guidance for evaluating progress towards elimination of measles and rubella","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2021.04.027_b0095","unstructured":"Pan American Health Organization. Plan of Action for Maintaining Measles, Rubella, and Congenital Rubella Syndrome Elimination in the Region of the Americas: Final Report. 55th Direction Council; 66th session of the WHO Regional Committee for the Americas; 26-30 September 2016; Washington, DC. Washington, DC: PAHO; 2012 (Resolution CD55\/INF\/10)."},{"key":"10.1016\/j.vaccine.2021.04.027_b0100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3201\/eid2504.181305","article-title":"Resurgence of vaccine-preventable diseases in venezuela as a regional public health threat in the Americas","volume":"25","author":"Paniz-Mondolfi","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.04.027_b0105","first-page":"S27","article-title":"The theory of measles elimination: implications for the design of elimination strategies","volume":"189","author":"Gay","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.027_b0110","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/S1473-3099(17)30307-9","article-title":"The basic reproduction number (R0) of measles: a systematic review","volume":"17","author":"Guerra","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.027_b0115","first-page":"205","article-title":"Measles vaccines: WHO position paper \u2013 April 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2021.04.027_b0120","unstructured":"McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 2013;62(RR-4):1-34."},{"key":"10.1016\/j.vaccine.2021.04.027_b0125","doi-asserted-by":"crossref","unstructured":"Fine PEM, Mulholland K, Scott JA, Edmunds WJ. Community Protection in Ploktin\u2019s Vaccines 7th edition. Plotkin SA, Orenstein WA, Offit PA, Edwards KM eds. Elsevier 2018:1512-153.","DOI":"10.1016\/B978-0-323-35761-6.00077-8"},{"key":"10.1016\/j.vaccine.2021.04.027_b0130","first-page":"301","article-title":"Rubella vaccines: WHO position paper","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.04.027_b0135","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/infdis\/jir065","article-title":"Biological feasibility of measles eradication","volume":"204","author":"Moss","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.027_b0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2307\/4592985","article-title":"Epidemiologic basis for eradication of measles in 1967","volume":"82","author":"Sencer","year":"1967","journal-title":"Public Health Report"},{"key":"10.1016\/j.vaccine.2021.04.027_b0145","unstructured":"Summary of the 14th Meeting of the International Task Force for Disease Eradication, 2009 (available at http:\/\/www.cartercenter.org\/resources\/pdfs\/news\/health_publications\/itfde\/ITFDEsum0609.pdf )."},{"key":"10.1016\/j.vaccine.2021.04.027_b0150","first-page":"61","article-title":"Meeting of the International Task Force for Disease Eradication, November 2015","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2021.04.027_b0155","unstructured":"World Health Organization. Global Measles and Rubella Strategic Plan: 2012-2020 (http:\/\/apps.who.int\/iris\/bitstream\/10665\/44855\/1\/9789241503396_eng.pdf)."},{"key":"10.1016\/j.vaccine.2021.04.027_b0160","unstructured":"https:\/\/www.who.int\/emergencies\/ten-threats-to-global-health-in-2019"},{"key":"10.1016\/j.vaccine.2021.04.027_b0165","unstructured":"World Health Organization. Measles - Vaccine Preventable Diseases Surveillance Standards, 2018. (available at https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/WHO_SurveillanceVaccinePreventable_11_Measles_R2.pdf?ua=1 )"},{"key":"10.1016\/j.vaccine.2021.04.027_b0170","unstructured":"World Health Organization. Rubella - Vaccine Preventable Diseases Surveillance Standards, 2018. (available at https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/WHO_SurveillanceVaccinePreventable_20_Rubella_R2.pdf?ua=1)"},{"key":"10.1016\/j.vaccine.2021.04.027_b0175","unstructured":"https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/WHO_SurveillanceVaccinePreventable_03_CRS_R2.pdf?ua=1"},{"key":"10.1016\/j.vaccine.2021.04.027_b0180","first-page":"97","article-title":"Roadmap to elimination standard measles and rubella surveillance","volume":"92","author":"Sniadack","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2021.04.027_b0185","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1016\/S2214-109X(18)30492-3","article-title":"Classification of global measles cases in 2013\u201317 as due to policy or vaccination failure: a retrospective review of global surveillance data","volume":"7","author":"Patel","year":"2019","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.vaccine.2021.04.027_b0190","unstructured":"Susan Reef, Jennifer Harris, Alan Ou, Ty Kraniak. Guidance to Increasing Population Immunity against Measles and Rubella. https:\/\/www.who.int\/immunization\/sage\/meetings\/2018\/october\/3_Country_classification_Guidance_measles_session_yellow_book_doc.pdf?ua=1"},{"key":"10.1016\/j.vaccine.2021.04.027_b0195","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1016\/j.vaccine.2019.05.096","article-title":"An evolution in thinking to support the post 2020 global vaccine strategy: The application of complexity and implementation science","volume":"37","author":"Dowell","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.027_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2019.01.081","article-title":"Accelerating measles and rubella elimination through research and innovation \u2013- findings from the measles & rubella initiative research prioritization process, 2016","author":"Grant","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.027_b0205","doi-asserted-by":"crossref","unstructured":"Nnadi C, Etsano A, Uba B, Ohuabunwo C, Melton M, Wa Nganda G, et al.. Approaches to vaccination among populations in areas of conflict. J Infect Dis 2017;216(suppl_1):S368-S372.","DOI":"10.1093\/infdis\/jix175"},{"key":"10.1016\/j.vaccine.2021.04.027_b0210","unstructured":"https:\/\/www.who.int\/immunization\/programmes_systems\/vaccine_hesitancy\/en\/"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.04.027_b0215","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/infdis\/jir130","article-title":"Is there enough vaccine to eradicate measles? An integrated analysis of measles-containing vaccine supply and demand","volume":"204","author":"Smith","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.027_b0220","unstructured":"https:\/\/www.who.int\/immunization\/programmes_systems\/procurement\/v3p\/platform\/module1\/en\/"},{"key":"10.1016\/j.vaccine.2021.04.027_b0225","first-page":"97","article-title":"Roadmap to elimination standard measles and rubella surveillance","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2021.04.027_b0230","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1377\/hlthaff.2015.1005","article-title":"Combining global elimination of measles and rubella with strengthening of health systems in developing countries","volume":"35","author":"Andrus","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.vaccine.2021.04.027_b0235","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1586\/14760584.2016.1165614","article-title":"Beyond vertical and horizontal programs: a diagonal approach to building national immunization programs through measles elimination","volume":"15","author":"Orenstein","year":"2016","journal-title":"Expert Review of Vaccines"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.04.027_b0240","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1093\/infdis\/jir090","article-title":"How can measles eradication strengthen health care systems?","volume":"204","author":"Griffiths","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.027_b0245","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1016\/j.vaccine.2018.07.029","article-title":"Strengthening routine immunization through measles-rubella elimination","volume":"36","author":"Biellik","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.027_b0250","unstructured":"Polio Endgame Strategy 2019-2023: Eradication, integration, certification and containment. Geneva: World Health Organization; 2019 (WHO\/Polio\/19.04)."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.04.027_b0255","doi-asserted-by":"crossref","first-page":"S540","DOI":"10.1093\/infdis\/jiu345","article-title":"Global polio eradication initiative: lessons learned and legacy","volume":"210","author":"Cochi","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.027_b0260","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/14760584.2017.1393337","article-title":"Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach","volume":"16","author":"Goodson","year":"2017","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.vaccine.2021.04.027_b0265","unstructured":"http:\/\/polioeradication.org\/who-we-are\/governance-and-structure\/"},{"key":"10.1016\/j.vaccine.2021.04.027_b0270","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1016\/j.vaccine.2019.03.035","article-title":"Potential use of microarray patches for vaccine delivery in low- and middle- income countries","volume":"37","author":"Peyraud","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.027_b0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2015.11.019","article-title":"Microneedle patches for vaccination in developing countries","volume":"240","author":"Arya","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2021.04.027_b0280","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1017\/S0950268815000540","article-title":"Investigation of a measles outbreak in Zimbabwe, 2010: potential of a point of care test to replace laboratory confirmation of suspected cases","volume":"143","author":"Shonhai","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.04.027_b0285","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/infdis\/jiy137","article-title":"Serological surveys for measles and rubella elimination: benefits and challenges","volume":"218","author":"Winter","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.027_b0290","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1016\/j.vaccine.2019.08.050","article-title":"Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis","volume":"37","author":"Zimmermann","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.027_b0295","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.vaccine.2014.11.050","article-title":"Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy","volume":"33","author":"Verguet","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.027_b0300","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1002\/sim.8290","article-title":"Estimation and prediction for a mechanistic model of measles transmission using particle filtering and maximum likelihood estimation","volume":"38","author":"Eilertson","year":"2019","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2021.04.027_b0305","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1017\/S0950268812000131","article-title":"Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination","volume":"140","author":"Metcalf","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.04.027_b0310","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tpb.2011.12.001","article-title":"Structured models of infectious disease: inference with discrete data","volume":"82","author":"Metcalf","year":"2012","journal-title":"Theor Popul Biol"},{"key":"10.1016\/j.vaccine.2021.04.027_b0315","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3201\/eid2507.181703","article-title":"Facility-associated release of polioviruses into communities - Risks for the posteradication era","volume":"25","author":"Bandyopadhyay","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.04.027_b0320","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1093\/infdis\/jir133","article-title":"Risk analysis for measles reintroduction after global certification of eradication","volume":"204","author":"Sanders","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.027_b0325","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1542\/peds.2004-0440","article-title":"Measles vaccines and the potential for worldwide eradication of measles","volume":"114","author":"Meissner","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2021.04.027_b0330","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2468-2667(17)30026-9","article-title":"The price of delaying measles eradication","volume":"2","author":"Durrheim","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.vaccine.2021.04.027_b0335","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa060775","article-title":"Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States","volume":"355","author":"Parker","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.04.027_b0340","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2009-1653","article-title":"Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated","volume":"125","author":"Sugerman","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2021.04.027_b0345","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/infdis\/jir115","article-title":"Health care-associated measles outbreak in the United States after an importation: challenges and economic impact","volume":"203","author":"Chen","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.027_b0350","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamapediatrics.2018.1024","article-title":"Public health consequences of a 2013 measles outbreak in New York City","volume":"172","author":"Rosen","year":"2018","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.vaccine.2021.04.027_b0355","unstructured":"https:\/\/www.ohchr.org\/en\/professionalinterest\/pages\/crc.aspx"},{"key":"10.1016\/j.vaccine.2021.04.027_b0360","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.vaccine.2018.01.002","article-title":"and the Immunity of Canadians and Risk of Epidemics (iCARE) Network. Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review","volume":"36","author":"Guerra","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.027_b0365","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S1473-3099(19)30395-0","article-title":"Immunogenicity, effectiveness, and safety of measles vaccination in children younger than 9 months: a systematic review and meta-analysis","volume":"19","author":"Lochlainn","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.027_b0370","first-page":"460","article-title":"Is there evidence for waning measles vaccine effectiveness?","volume":"38","author":"Hughes","year":"2020","journal-title":"A systematic review. Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.027_b0375","unstructured":"https:\/\/ourworldindata.org\/urbanization"},{"key":"10.1016\/j.vaccine.2021.04.027_b0380","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1126\/science.aau6299","article-title":"Measles and the canonical path to elimination","volume":"364","author":"Graham","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2021.04.027_b0385","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMp1300765","article-title":"Go big and go fast\u2013vaccine refusal and disease eradication","volume":"368","author":"Omer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.04.027_b9000","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2468-2667(17)30026-9","article-title":"Crowcroft Natasha The price of delaying measles eradication","volume":"2","author":"David","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.vaccine.2021.04.027_b9005","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1016\/j.vaccine.2014.10.061","article-title":"Strebel Peter Measles - The epidemiology of elimination","volume":"32","author":"David","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:56:11Z","timestamp":1759402571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21004746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":79,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0264410X21004746"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility assessment of measles and rubella eradication","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}